International-Drug-Development-Biotech

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 20.0

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 6

Loading Chart...

8 inventors (with patents filed for the assignee):

Claudine Vermot-Desroches (5 out of 6 patents)

Boris Sebastien Vuillermoz (2 out of 2 patents)

Gilles Salles (1 out of 1 patent)

4. Marc Godinat (1 out of 1 patent)

5. Bruno Cavallini (1 out of 1 patent)

6. Chanthy Kong-Flohr (1 out of 1 patent)

7. Benoît Milcent (1 out of 1 patent)

8. Hélène Rouquette (1 out of 1 patent)

9. Marie Alexandra Albaret (1 patent)

10. Jean-Jacques Diaz (3 patents)

11. Jean-Christophe Saurin (2 patents)

12. Hichem Claude Mertani (1 patent)

13. Boris Vuillermoz (1 patent)

5 patents: Sort by Forward Citations

1. 12077597 - Anti-CD5 antibodies and methods of use thereof (2024-09-03),

2. 11634488 - Treatment of B cell malignancies using afucosylated pro-apoptotic anti-CD19 antibodies in combination with anti CD20 antibodies or chemotherapeutics (2023-04-25),

3. RE49192 - Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile (2022-08-29),

4. 9663583 - Anti-CD19 antibody having ADCC and CDC functions and improved glycosylation profile (2017-05-30),

5. 9120856 - Anti-CD19 antibody having ADCC function with improved glycosylation profile (2015-09-01),

Company Overview

International Drug Development Biotech specializes in the research and development of innovative pharmaceutical solutions. The company focuses on advancing drug development processes through cutting-edge biotechnology, aiming to bring new therapies to market efficiently. With a commitment to improving patient outcomes, the firm collaborates with various stakeholders in the healthcare sector, including academic institutions and regulatory bodies. Their expertise spans multiple therapeutic areas, ensuring a robust pipeline of potential treatments. The company is dedicated to maintaining high standards of quality and compliance throughout the drug development lifecycle.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#54 in Lyon

#2,868 in France

Lyon, France

International-Drug-Development-Biotech

Forward Citations = 6

8 inventors:

Claudine Vermot-Desroches (5 out of 6 patents)

Boris Sebastien Vuillermoz (2 out of 2 patents)

Gilles Salles (1 out of 1 patent)

4. Marc Godinat (1 out of 1 patent)

5. Bruno Cavallini (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: International-Drug-Development-Biotech. Retrieved from https://idiyas.com/company/international-drug-development-biotech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]